Factsheet
As of 10 Jan 2025
IP
-
Consumer Products
/
Personal Products & Pharmaceuticals
CG Report :
-
SET ESG Ratings :
-
Business Type
Research & development and distribution of healthcare products and aesthetic innovation products for human including health products for pets and livestock animals
302.67
1,828.14
2,672.53
129.35
18.85
3.02
7.30 /
2.92
209.52
0.95
Company Profile
140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong Sub-District, Bang Rak District Bangkok 10500
0-2634-0225
0-2634-0135
ADVISORY PLUS CO., LTD.
05 Nov 2019
7.00 @Par Value
0.50
Baht
0.50
Baht
Old -
: New - @
-
Shareholders
As of -
6,565 (as of 15 Mar 2024)
48.79% (as of 15 Mar 2024)
0.15% (as of 10 Jan 2025)
49.00% (as of 10 Jan 2025)
6,471 (as of 14 Mar 2023)
44.43% (as of 14 Mar 2023)
0.39% (as of 10 Jan 2025)
Board of Directors / Management
5 Yr Price Performance (Adjusted Price)
Change
Price Performance (Adjusted Price)
Statistics
Accumulated: Turnover Ratio, Value Trade/Day
Rate of Return
Dividend
Latest News
Auditor (Effective Until 31 Dec 2024)
Miss SIRIWAN NITDAMRONG (EY OFFICE LIMITED)MRS. SARINDA HIRUNPRASURTWUTTI (EY OFFICE LIMITED)MISS SATIDA RATANANURAK (EY OFFICE LIMITED)MS. KAMONTIP LERTWITWORATEP (EY OFFICE LIMITED)
Unqualified opinion with an emphasis of matters
31 Dec
Financial Statements Submission Information
Financial Data
Statement of Financial Position Unit: M.Baht
Statement of Comprehensive Income Unit: M.Baht
Statement of Cash Flow Unit: M.Baht
Ratios Annualized : ROE,
ROA
Growth Rate (%)
Cash Cycle Annualized
Capital Movement (Last 3 Year)
Information only PP, PO, XR and XD
Trading Sign (Latest)
- Calculated from adjusted price
- Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
- The information is quarterly updated within 7 business days after the new financial statement is submitted
- Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.